02/12/2025
3:29 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:34 AM | FMR LLC (Filed by)
Vor Biopharma (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
3:35 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:36 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:37 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
8:19 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:20 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:22 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
8:23 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
11:15 PM | Vor Biopharma (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for VOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vor Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
01/29/2025
4:24 PM | Vor Biopharma (Filer)
| Form 424B3 | |
01/21/2025
3:24 PM | Vor Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
5:39 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2025
5:41 PM | Kalir Erez (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
8:06 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:53 PM | Reprogrammed Interchange LLC (Filed by)
Vor Biopharma (Subject)
| Form SCHEDULE 13D | |
01/02/2025
6:37 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:42 PM | Hoffman Reid (Reporting)
Reprogrammed Interchange LLC (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
5:51 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
5:52 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:17 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2024
8:05 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
6:39 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
| Form SC 13G/A | |
11/08/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:20 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:16 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
3:17 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:05 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:06 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:29 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:30 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Watch This Robotics Demo Before March 17th (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
07/19/2024
4:04 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
4:22 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/04/2024
5:09 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:38 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
3:54 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:10 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:40 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:39 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
3:05 PM | Vor Biopharma (Filer)
| Form DEF 14A | |
04/09/2024
3:07 PM | Vor Biopharma (Filer)
| Form DEFA14A | |
04/09/2024
3:10 PM | Vor Biopharma (Filer)
| Form ARS | |
